NCI Grants Establish 18 Biomarkers Developmental Laboratories

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 12
Volume 8
Issue 12

BETHESDA, Md-Nearly $8 million in grants will help 17 organizations establish 18 Biomarkers Developmental Laboratories, part of the National Cancer Institute’s new Early Detection Research Network. The laboratories are charged with identifying, characterizing, and refining techniques for finding molecular, genetic, and biologic biomarkers.

BETHESDA, Md—Nearly $8 million in grants will help 17 organizations establish 18 Biomarkers Developmental Laboratories, part of the National Cancer Institute’s new Early Detection Research Network. The laboratories are charged with identifying, characterizing, and refining techniques for finding molecular, genetic, and biologic biomarkers.

Two laboratories will be established at the University of Maryland School of Medicine. Other grants went to the University of Colorado, Yale University, Lombardi Cancer Center, the University of South Florida, Northwestern University, Johns Hopkins University, the University of Michigan, Genetica, Inc. (Cold Spring, NY), Mount Sinai School of Medicine, Duke Medical Center, Thomas Jefferson University, the University of Pittsburgh, M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center (Dallas), Eastern Virginia Medical School, and the University of Washington.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
6371178759112
Focused, high-dose radiotherapy doses may prolong survival and the interval to subsequent therapy for patients with advanced prostate cancer.
Data show increasing use of proton therapy overall but widening gaps in populations who have access to this treatment, says Curtiland Deville Jr., MD.
Related Content